StockData

Allarity Therapeutics vs Lisata Therapeutics

ALLR and LSTA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALLR and LSTA compare

Allarity Therapeutics is the larger company, worth 1.4 times as much as Lisata Therapeutics ($13.9M against $9.8M).

Lisata Therapeutics scores higher on the StockData Score (6 against 1 for Allarity Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALLRLSTA
Size and price
Market cap$13.9M$9.8M
Share price$0.875$1.09
Change, 1 year−26.5%−47.3%
Change, 5 years–−92.6%
Beta (5Y)1.41−1.65
Employees821
StockData Score
Total score16 (better)
Valuation score01 (better)
Growth score00
Performance score00
Health score15 (better)
Dividend score00
Valuation
P/S–98.2×
P/B3.9×1.2× (better)
FCF yield–−125%
Growth
Revenue growth (TTM)–−90.7%
Profitability
Operating margin–−16427%
Net margin–−14621%
FCF margin–−12323%
Return on equity−157%−99.9% (better)
Return on invested capital−957% (better)−1645%
Financial health
Debt / equity5.90 (better)0.00
Interest coverage−10.1×–
Current ratio1.113.69 (better)
Altman Z-score−6.64 (better)−74.72
Piotroski F-score4 (better)1
Dividends and buybacks
Buyback yield6.4% (better)−6.0%
Shareholder yield6.4% (better)−6.0%
Ownership
Held by institutions8.1%12.1%
Held by insiders6.3%11.6%
Short interest, % of float1.5%0.43%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.